COMMUNIQUÉS West-GlobeNewswire

CareDx Drives Personalized Medicine in Transplantation at CEOT

20/02/2019 - 14:00

AlloSure highlighted at Cutting Edge in Transplantation conference in multiple sessions BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the [...]

miRagen Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results and Host a Conference Call on March 13th

20/02/2019 - 14:00

BOULDER, Colo., Feb. 20, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]

Zogenix to Present at the 8th Annual SVB Leerink Global Healthcare Conference

20/02/2019 - 14:00

EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will [...]

Mersana Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference

20/02/2019 - 14:00

CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]

VBL Therapeutics Awarded $2.9 Million Non-Dilutive Grant by the Israel Innovation Authority

20/02/2019 - 14:00

TEL AVIV, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (the “Company”) today announced that it has been awarded a non-dilutive grant of over 10 million New Israeli Shekels (approximately $2. [...]

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast

20/02/2019 - 14:00

NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference

20/02/2019 - 14:00

TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief [...]

Principia Biopharma to Present at 8th Annual SVB Leerink Global Healthcare Conference

20/02/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]

CymaBay Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference

20/02/2019 - 14:00

NEWARK, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Allogene Therapeutics Enters Lease to Build Manufacturing Facility to Develop and Commercialize Allogeneic CAR T (AlloCAR T™) Therapies

20/02/2019 - 14:00

State-of-the-Art Manufacturing Facility to be Located in the San Francisco East Bay Area Allogene Committed to Advanced Cell Manufacturing for Long-Term Clinical and Commercial AlloCAR T™ Production SOUTH SAN FRANCISCO [...]

BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific

20/02/2019 - 14:00

Enters into an Agreement to Distribute its Deep Transcranial Magnetic Stimulation System in South Korea JERUSALEM, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN) , a global leader in the advanced non- [...]

Fulgent Genetics to Announce Fourth Quarter and Full Year 2018 Financial Results on Thursday February 28, 2019

20/02/2019 - 14:00

TEMPLE CITY, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2018 financial [...]

Progressive Care Inc. Announces Best January in Company History

20/02/2019 - 14:00

MIAMI, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]

RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, U.S. Operations

20/02/2019 - 14:00

TEL-AVIV, Israel and RALEIGH, N.C., Feb. 20, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

BioSig Announces Successful First-In-Human Use of PURE EP System

20/02/2019 - 13:52

Early Results Suggest Improved Cardiac Signal Detection and Fidelity Santa Monica, CA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary [...]

AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial

20/02/2019 - 13:45

Initial top line data of MS1819-SD in Cystic Fibrosis Patients expected in mid-2019. First patients dosed in open-label, cross-over Phase II OPTION study with MS1819-SD for exocrine pancreatic insufficiency in cystic [...]

FIT Biotech Oy: Liquidity crisis, request for a tranche and changes to financial calendar and date of the Annual General Meeting

20/02/2019 - 13:30

FIT Biotech Oy Company release 20.02.2019 at 14:30 EET Liquidity crisis, request for a tranche and changes to financial calendar and date of the Annual General Meeting Despite the financing agreement in force, Alpha [...]

Moleculin Announces Outlicensing Deal To Accelerate Preclinical and Clinical Development

20/02/2019 - 13:30

HOUSTON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Xeris Pharmaceuticals to Participate at SVB Leerink Global Healthcare Conference

20/02/2019 - 13:30

CHICAGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]